Wockhardt share price has plunged 4% and is presently trading at Rs 1,005.9.
Meanwhile, the BSE HEALTHCARE index is at 42,578.0 (down 0.4%).
Among the top losers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (down 2.8%) and SUN PHARMA ADV. RES. (down 1.8%).
AJANTA PHARMA (up 2.9%) and ERIS LIFESCIENCES (up 2.5%) are among the top gainers today.
Over the last one year, Wockhardt has moved up from Rs 230.0 to Rs 1,005.9, registering a gain of Rs 775.9 (up 337.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,859.6 to 42,578.0, registering a gain of 52.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 136.4%), Glenmark Pharma (up 122.3%) and SUVEN PHARMACEUTICALS (up 108.7%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,007.9 (up 0.3%).
The top gainers among the BSE Sensex today are Bajaj Finance (up 2.6%) and Bajaj Finserv (up 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 25,098.7 (up 0.2%). Bajaj Finance and Bajaj Finserv are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,996.6 to 82,007.9, registering a gain of 17,011.3 points (up 26.2%).
Wockhardt net profit grew 88.2% YoY to Rs -160 million for the quarter ended June 2024, compared to a loss of Rs 1,360 million a year ago. Net sales rose 14.8% to Rs 7,390 million during the period as against Rs 6,440 million in April-June 2023.
For the year ended March 2024, Wockhardt reported 24.0% increase in net profit to Rs -4,720 million compared to net loss of Rs 6,210 million during FY23. Revenue of the company grew 5.5% to Rs 27,980 million during FY24.
The current Price to earnings ratio of Wockhardt, based on rolling 12 month earnings, stands at -43.8.
Equitymaster requests your view! Post a comment on "Wockhardt Plunges 4%; BSE HEALTHCARE Index Down 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!